Financial Ratios

SANDU PHARMACEUTICALS LTD.

NSE : NABSE : 524703ISIN CODE : INE751D01014Industry : Pharmaceuticals & DrugsHouse : Private
BSE61.30-1.69 (-2.68 %)
PREV CLOSE ( ) 62.99
OPEN PRICE ( ) 63.89
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 3387
TODAY'S LOW / HIGH ( )61.01 63.89
52 WK LOW / HIGH ( ) 4985
NSE
This Company is not listed in NSE
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)1.581.801.381.020.94
   CEPS(Rs)2.112.412.081.801.84
   DPS(Rs)0.750.750.500.000.00
   Book NAV/Share(Rs)31.4730.7129.6328.2227.39
   Tax Rate(%)31.3631.3935.0121.6234.25
Margin Ratios
   Core EBITDA Margin(%)3.814.393.123.164.24
   EBIT Margin(%)3.523.702.592.794.11
   Pre Tax Margin(%)3.403.542.431.902.06
   PAT Margin (%)2.332.431.581.491.35
   Cash Profit Margin (%)3.123.242.382.632.64
Performance Ratios
   ROA(%)2.953.302.471.691.52
   ROE(%)5.306.295.033.663.53
   ROCE(%)7.949.357.875.797.58
   Asset Turnover(x)1.261.361.571.141.12
   Sales/Fixed Asset(x)2.432.502.671.881.92
   Working Capital/Sales(x)5.615.563.844.377.94
Efficiency Ratios
   Fixed Capital/Sales(x)0.410.400.370.530.52
   Receivable days24.5326.0226.4335.7042.42
   Inventory Days71.4962.4467.19104.0491.19
   Payable days89.0368.8765.7572.6152.31
Valuation Parameters
   PER(x)33.0939.0023.1611.5523.07
   PCE(x)24.7129.2415.356.5411.83
   Price/Book(x)1.662.291.080.420.80
   Yield(%)1.441.071.560.000.00
   EV/Net Sales(x)0.740.880.230.170.42
   EV/Core EBITDA(x)17.0919.555.814.207.80
   EV/EBIT(x)20.9423.837.615.9310.26
   EV/CE(x)0.891.170.290.190.48
   M Cap / Sales0.770.950.430.170.31
Growth Ratio
   Net Sales Growth(%)-0.2311.4821.28-1.980.83
   Core EBITDA Growth(%)-4.7425.6823.28-28.473.06
   EBIT Growth(%)-5.2335.1132.65-33.292.18
   PAT Growth(%)-4.1245.4751.677.6519.16
   EPS Growth(%)-12.5530.7835.587.6619.15
Financial Stability Ratios
   Total Debt/Equity(x)0.000.000.000.060.32
   Current Ratio(x)1.841.992.441.981.45
   Quick Ratio(x)0.811.041.550.710.49
   Interest Cover(x)28.8922.0615.623.112.01
   Total Debt/Mcap(x)0.000.000.000.150.40

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.